Provided by Tiger Trade Technology Pte. Ltd.

Merck

120.84
+0.55000.46%
Post-market: 120.80-0.0400-0.03%19:57 EDT
Volume:6.35M
Turnover:768.62M
Market Cap:299.93B
PE:16.60
High:122.19
Open:120.88
Low:120.27
Close:120.29
52wk High:125.14
52wk Low:73.31
Shares:2.48B
Float Shares:2.48B
Volume Ratio:0.68
T/O Rate:0.26%
Dividend:3.24
Dividend Rate:2.68%
EPS(TTM):7.28
EPS(LYR):7.28
ROE:36.88%
ROA:12.04%
PB:5.70
PE(LYR):16.60

Loading ...

Merck & Co: Expanded Label for Once-Yearly Parasiticide Treatment for Dogs NOW Includes Haemaphysalis Longicornis & Amblyomma Maculatum for 12 Months

THOMSON REUTERS
·
Mar 19

Merck's Global Chief Sustainability Officer: Redefining Sustainability - From Compliance Investment to Innovation Dividends

Deep News
·
Mar 18

Analysts Offer Insights on Healthcare Companies: Rhythm Pharmaceuticals (RYTM) and Merck & Company (MRK)

TIPRANKS
·
Mar 17

Merck to present long-term efficacy of GARDASIL 9, GARDASIL at EUROGIN Congress

TIPRANKS
·
Mar 17

Merck to present long-term Gardasil 9 and Gardasil efficacy data at EUROGIN 2026

Reuters
·
Mar 17

Rose the dog might have just heralded the age of programmable medicine - and here are the stocks that benefit

Dow Jones
·
Mar 17

Merck ACC.26 Data Highlights Cardio Pulmonary Pipeline Beyond Keytruda

Simply Wall St.
·
Mar 17

US judge blocks efforts to reshape childhood vaccine policy

Reuters
·
Mar 17

Merck Highlights New Data From Cardio-Pulmonary Pipeline at Acc.26 Showcasing Commitment to Advance Innovative Research

THOMSON REUTERS
·
Mar 16

What Are Defensive Stocks? Best Defensive Stocks to Buy in 2026

TradingKey
·
Mar 16

J.P. Morgan Remains a Buy on Merck KGaA (0O14)

TIPRANKS
·
Mar 16

Option Movers | Micron Sees 54% Call Options; Microsoft Shows Highest Bullish Sentiment

Option Movers
·
Mar 16

Kepler Capital Sticks to Its Buy Rating for Merck KGaA (0O14)

TIPRANKS
·
Mar 15

Merck & Company (MRK) Gets a Hold from Bernstein

TIPRANKS
·
Mar 13

Barclays Keeps Their Buy Rating on Merck & Company (MRK)

TIPRANKS
·
Mar 13

Merck Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Mar 12

Wells Fargo Adjusts Price Target on Merck & Co. to $150 From $135, Maintains Overweight Rating

MT Newswires Live
·
Mar 12

Merck & Co Inc : Wells Fargo Raises Target Price to $150 From $135

THOMSON REUTERS
·
Mar 12

Merck price target raised to $150 from $135 at Wells Fargo

TIPRANKS
·
Mar 12

Barclays Sticks to Their Hold Rating for Merck KGaA (0O14)

TIPRANKS
·
Mar 12